I reckon that the sales performance had been an epic fail. I give the sales and marketing people an "F" for failing to make significant progress in market share for what is clearly a far superior product. I very much doubt that Admedus are anywhere near the sales volumes that they would have hoped for.
As much as i believe in the products and vaccines future, investors are staying away. One look at the chart for the last 2.5 years and you would simply decide to wait for the downward trend to change direction. We need some significantly good news to get it moving in the right direction again and then it will hopefully accelerate.
Good luck to all LT holders and i hope that seriously good news comes soon
Cardiocel Revenue and Company Growth, page-64
-
- There are more pages in this discussion • 286 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.05 | $14.05 | $14.00 | $10.45K | 747 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 551 | $13.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.99 | 400 | 1 |
View Market Depth
| Last trade - 10.18am 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |